AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2019 Innovations in T Cells, Semiconductors, Vaccines, Machine Learning & Recombinant Proteins - ResearchAndMarkets.com

November 6, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 6, 2019--

The “Innovations in T Cells, Semiconductors, Vaccines, Machine Learning, and Recombinant Proteins” report has been added to ResearchAndMarkets.com’s offering.

This edition of the Inside R&D TechVision Opportunity Engine (TOE) features trends and innovations in the field of cancer and tumor therapy, semiconductors, machine learning, and vaccines. It also provides intelligence on the use of novel techniques that reduce the cost involved in dialysis and the use of T-cells in cancer therapy.

Key Topics Covered

For more information about this report visit https://www.researchandmarkets.com/r/v0bah2

View source version on businesswire.com:https://www.businesswire.com/news/home/20191106005753/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: SEMICONDUCTOR HEALTH TECHNOLOGY OTHER TECHNOLOGY PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/06/2019 11:44 AM/DISC: 11/06/2019 11:44 AM

http://www.businesswire.com/news/home/20191106005753/en